MUNICH — As the healthcare sector undergoes rapid digital transformation, Fraunhofer-Gesellschaft is at the forefront of innovation, leveraging artificial intelligence (AI) to enhance patient care, streamline processes, and foster effective stakeholder networking. Nine Fraunhofer units are set to showcase groundbreaking research results at the DMEA 2024 trade show in Berlin from April 9 to 11, 2024, offering insights into the future of healthcare IT at Booth D-108 in Hall 2.2, according to a press release published on EuropaWire.

At the core of Fraunhofer’s health research agenda are tools and technologies powered by AI that support diagnostics, medical decisions, and personalized healthcare delivery. For instance, the Fraunhofer Institute for Digital Medicine MEVIS will unveil four AI-based applications at DMEA 2024, including solutions for harmonizing clinical data, reducing algorithm development time, aiding surgical interventions, and supporting breast cancer patients with personalized guidance.

Additionally, the Fraunhofer Institute for Telecommunications, Heinrich Hertz Institut, HHI, will present advances in light fidelity (LiFi) technology tailored for medical applications, enabling secure mobile communication through optical wireless transmission. Meanwhile, the Fraunhofer Center for Digital Diagnostics ZDD will showcase innovative concepts targeting healthcare in rural areas, spanning from intelligent wound management to fully automated health centers.

Cohort analysis, essential for personalized medicine, will be highlighted by the Fraunhofer Institute for Computer Graphics Research IGD, which developed a Parkinson’s monitor to aid medical staff and patients in understanding disease progression and individual risk assessment.

Moreover, Fraunhofer Institute for Intelligent Analysis and Information Systems IAIS will demonstrate clinical artificial intelligence solutions for pharmacology and hospitals, enhancing efficiency and precision in healthcare. The Fraunhofer Center for Maritime Logistics and Services CML will present SCEDAS software for efficient surgery planning, optimizing OR resource utilization.

Under the theme of “trustworthy digital health,” the Fraunhofer Institute for Cognitive Systems IKS will focus on explainable AI in medical diagnostics and data-efficient AI for early cancer detection. Meanwhile, patient applications such as veinXam and Guardio developed by Fraunhofer IGD aim to improve healthcare delivery and telemedicine implementation.

Finally, Fraunhofer Institute for Applied Information Technology FIT will showcase development tools for deploying digital health solutions quickly, while Fraunhofer Institute for Software and Systems Engineering ISST will present software technology for transparent and interoperable medical data spaces.

Fraunhofer-Gesellschaft’s presence at DMEA 2024 underscores its commitment to driving innovation and creating value for patients and healthcare providers through cutting-edge AI technologies.